Oxford vaccine to cost Rs200 per vial in India, SII likely to get purchase order on Monday
The vaccine rollout is expected on 16 January
The Oxford vaccine in india is likely to be priced at Rs200 a vial and the Indian government may place an order on Monday.
"The purchase order for Covishield vaccines is expected today with roll out either today or tomorrow," sources said, reports the NDTV.
"A few million doses of Covishield will be supplied every week. 11 million doses may be supplied in the initial lot," sources said.
Keep updated, follow The Business Standard's Google news channel
The vaccine rollout is expected on 16 January, the government said on the weekend.
The Oxford-AstraZeneca vaccine against the coronavirus, "Covishield", was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this month.
Serum chief executive Adar Poonawalla said that the vaccine would be priced at about Rs,000 rupees per dose for the private market in India and would cost the government about Rs250 Indian rupees ($3.40) per dose.
India government plans to cover 300 million people in the first part of the programme in which health workers, frontline staff such as police and people over the age of 50 and those with co-morbidities will be covered first.
That will require 600 million doses and Serum, the world's largest manufacturer of vaccines has stockpiled 50 million doses for immediate distribution.
